Evidence map›Paper›PMID 36227923›Full record

ArticlePLoS neglected tropical diseases2022

Wolbachia wAlbB inhibit dengue and Zika infection in the mosquito Aedes aegypti with an Australian background.

Leon E Hugo, Gordana Rašić, Andrew J Maynard, Luke Ambrose, Catherine Liddington, Callum J E Thomas, Nisa Suraj Nath, Melissa Graham, Clay Winterford, B M C Randika Wimalasiri-Yapa and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Strategies forOne health (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Introduction ofiScience · 2024
    Article
  13. A comprehensive review ofFrontiers in immunology · 2024
    Review
  14. Article
  15. Article
  16. Pathogens and global health · 2023
    Article
  17. Genome-wide detection ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Leon E HugoQIMR Berghofer, Brisbane, Queensland, Australia.ORCID 0000-0002-6767-9850
Gordana RašićQIMR Berghofer, Brisbane, Queensland, Australia.
Andrew J MaynardSchool of Biological Sciences, University of Queensland, Brisbane, Australia.
Luke AmbroseSchool of Biological Sciences, University of Queensland, Brisbane, Australia.
Catherine LiddingtonCSIRO, Brisbane, Queensland, Australia.
Callum J E ThomasSchool of Biological Sciences, University of Queensland, Brisbane, Australia.
Nisa Suraj NathQIMR Berghofer, Brisbane, Queensland, Australia.
Melissa GrahamQIMR Berghofer, Brisbane, Queensland, Australia.
Clay WinterfordQIMR Berghofer, Brisbane, Queensland, Australia.
B M C Randika Wimalasiri-YapaDepartment of Medical Laboratory Sciences, The Open University of Sri Lanka, Colombo, Sri Lanka.
Zhiyong XiDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America.
Nigel W BeebeSchool of Biological Sciences, University of Queensland, Brisbane, Australia.
Gregor J DevineQIMR Berghofer, Brisbane, Queensland, Australia.ORCID 0000-0001-6312-0390
QIMR Berghofer Medical Research Institute · AUThe University of Queensland · AUCommonwealth Scientific and Industrial Research Organisation · AUMichigan United · USOpen University of Sri Lanka · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological control of mosquito vectors using the endosymbiotic bacteria Wolbachia is an emerging strategy for the management of human arboviral diseases. We recently described the development of a strain of Aedes aegypti infected with the Wolbachia strain wAlbB (referred to as the wAlbB2-F4 strain) through simple backcrossing of wild type Australian mosquitoes with a wAlbB infected Ae. aegypti strain from the USA. Field releases of male wAlbB2-F4 mosquitoes resulted in the successful suppression of wild populations of mosquitoes in the trial sites by exploiting the strain's Wolbachia-induced cytoplasmic incompatibility. We now demonstrate that the strain is resistant to infection by dengue and Zika viruses and is genetically similar to endemic Queensland populations. There was a fourfold reduction in the proportion of wAlbB2-F4 mosquitoes that became infected following a blood meal containing dengue 2 virus (16.7%) compared to wild type mosquitoes (69.2%) and a 6-7 fold reduction in the proportion of wAlbB2-F4 mosquitoes producing virus in saliva following a blood meal containing an epidemic strain of Zika virus (8.7% in comparison to 58.3% in wild type mosquitoes). Restriction-site Associated DNA (RAD) sequencing revealed that wAlbB2-F4 mosquitoes have > 98% Australian ancestry, confirming the successful introduction of the wAlbB2 infection into the Australian genomic background through backcrossing. Genotypic and phenotypic analyses showed the wAlbB2-F4 strain retains the insecticide susceptible phenotype and genotype of native Australian mosquitoes. We demonstrate that the Wolbachia wAlbB2-F4, in addition to being suitable for population suppression programs, can also be effective in population replacement programs given its inhibition of virus infection in mosquitoes. The ease at which a target mosquito population can be transfected with wAlbB2, while retaining the genotypes and phenotypes of the target population, shows the utility of this strain for controlling the Ae. aegypti mosquitoes and the pathogens they transmit.

Indexed as

AedesDengueDengue VirusInsecticidesWolbachiaZika VirusZika Virus InfectionAnimalsAustraliaDNAHumansMaleMosquito VectorsDNAInsecticides

Identifiers

PMID36227923
PMCPMC9562151
OpenAlexW4306154533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.